Annual report pursuant to section 13 and 15(d)

Note 10 - Commitments (Details)

v2.4.0.8
Note 10 - Commitments (Details) (USD $)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended 12 Months Ended
Sep. 30, 2012
Mar. 31, 2012
Sep. 30, 2012
Sep. 30, 2012
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2012
Paid [Member]
Co-Development Agreement [Member]
Dec. 31, 2012
Paid [Member]
Master Services and Software License Agreement [Member]
Dec. 31, 2012
Unpaid [Member]
Master Services and Software License Agreement [Member]
Dec. 31, 2012
Co-Development Agreement [Member]
Dec. 31, 2012
Shared Research Agreements [Member]
Dec. 31, 2012
Master Services and Software License Agreement [Member]
Previous Purchase [Member]
Dec. 31, 2012
Master Services and Software License Agreement [Member]
Additional Purchase [Member]
Dec. 31, 2012
Master Services and Software License Agreement [Member]
Sep. 30, 2012
Master Services and Software License Agreement [Member]
Dec. 31, 2012
Cardiac EP Business Participation Plan [Member]
Jun. 30, 2010
Cardiac EP Business Participation Plan [Member]
Note 10 - Commitments (Details) [Line Items]                                    
Operating Leases, Rent Expense         $ 145,000 $ 174,000 $ 181,000                      
Contractual Obligation               1,373,889 100,000 200,000 2,476,000 238,000       300,000    
Accounts Payable, Current         1,961,195 4,037,168           599,000            
Stock Issued During Period, Shares, Purchase of Assets (in Shares)                             1,500,000      
License Costs                         612,500 87,500        
Purchase Commitment, Remaining Minimum Amount Committed                             962,500      
Other Inventory, Noncurrent         1,137,500                   1,137,500      
Equity Method Investment, Ownership Percentage                                 3.70% 6.60%
Bonus Payment to Each Participant in Key Personnel Incentive Program upon a Sale Transaction 1,000,000   1,000,000 1,000,000                            
Incentive Bonus Payment to One of the Participants as a Percentage of Net Proceeds from the Sale Transaction 1.40%   1.40% 1.40%                            
Net Proceeds from the Sale Transaction, Threshold Amount 50,000,000   50,000,000 50,000,000                            
Maximum Additional Incentive Bonus Payment to One Participant 700,000   700,000 700,000                            
Other Operating Income (Expense), Net $ (76,622) $ 120,895 $ 882,537 $ (2,493,476) $ (2,577,069)